APA (7th ed.) Citation

Ibrahim, L., Diaz Granados, N., Jolkovsky, L., Brutsche, N., Luckenbaugh, D. A., Herring, W. J., . . . Zarate, J. (2012). A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. Journal of clinical psychopharmacology, 32(4), 551. https://doi.org/10.1097/JCP.0b013e31825d70d6

Chicago Style (17th ed.) Citation

Ibrahim, Lobna, Nancy Diaz Granados, Libby Jolkovsky, Nancy Brutsche, David A. Luckenbaugh, W Joseph Herring, William Z. Potter, and Jr Zarate. "A Randomized, Placebo-controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients with Treatment-resistant Major Depressive Disorder." Journal of Clinical Psychopharmacology 32, no. 4 (2012): 551. https://doi.org/10.1097/JCP.0b013e31825d70d6.

MLA (9th ed.) Citation

Ibrahim, Lobna, et al. "A Randomized, Placebo-controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients with Treatment-resistant Major Depressive Disorder." Journal of Clinical Psychopharmacology, vol. 32, no. 4, 2012, p. 551, https://doi.org/10.1097/JCP.0b013e31825d70d6.